retatrutide type 2 diabetes trial results 2024 2025 💉 A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with diabetes, a new phase 3 shows. is part of an emerging generation Clinical trials of subcutaneous tirzepatide,

The consistency of these improvements across study visits suggested sustained metabolic benefit rather than temporary fluctuations

IIH is caused by elevated CSF pressure without a structural cause

For longterm success, pick an approach thats based on whole foods, limits (but doesnt unnecessarily restrict) less healthful processed fare and teaches other tools, such as learning how to respond to your bodys appetite signals.

The program includes a dedicated physician or nurse practitioner, a registered dietitian , comprehensive lab testing (including metabolic panels and A1C monitoring), and continuous remote monitoring through connected devices

For maximum microbiome impact, consider a two-phase approach